NextCure, Inc. reported earnings results for the year ended December 31, 2020. For the year, revenue from former research and development arrangement was $22,378,000 against $6,347,000 a year ago. Loss from operations was $41,225,000 against $37,482,000 a year ago. Net loss was $36,603,000 against $33,737,000 a year ago. Net loss per common share - basic and diluted was $1.33 against $2.15 a year ago.